SLT for mild cognitive impairment

Do you have memory problems?


Did you know?

Mild cognitive impairment (MCI) is related to Alzheimer's disease, the most common type of dementia. MCI causes a slight but noticeable decline in mental abilities, such as memory and thinking. It is estimated one in three Australians over the age of 70 have MCI:

  • People with MCI have a higher risk of getting dementia
  • There are no effective treatments for MCI.

This study involves a 12-week clinical trial of Sailuotong (SLT), a standardised herbal medicine formula, for people with MCI. If you have problems with your memory, or a diagnosis of MCI, please read on.

Who can join?

  • Men and women over 60 years of age.
  • People who:
    • Have noticed a decline in their memory and/or other mental abilities.
    • Do not have a diagnosis of dementia.
    • Are right-handed.
    • Do not have other serious ongoing health problems.

What's involved?

  • A short screening session over the phone.
  • A face-to-face screening session.
  • Two tablets morning and night.
  • Travel to study centre at Western Sydney University, Campbelltown (NSW).
  • Six study visits over a 12-week period:
    • Physiological assessments
    • Mental ability assessments.

What are the benefits of participating?

  • The study drug has the potential to improve your memory and thinking, however, neither you nor the research team will know if you are taking the study drug or a placebo.
  • You will receive 12-weeks free supply of the study drug at the end of the trial.
  • You will receive feedback about your mental condition at the end of the study, and information on what you can do to reduce your risk of future cognitive decline including further clinical trial opportunities if applicable.
  • You will be reimbursed up to $180 for your travel expenses.

For more information, please contact:

Dr Genevieve Steiner
Phone: (02) 4620 3278